Biotech & Pharma Partnering Day: Tuesday, September 23

Understanding What Pharma Are Looking for When Making Partnerships

9:00 am The Importance of Dealmaking for Building World-Leading Cell Therapy Capabilities

  • Polly Brown Vice President & Head of Business Development, Oncology, Research & Development, AstraZeneca

Synopsis

  • Dealmaking has been pivotal for bringing in new talent, augmenting our pipeline and expanding our capabilities in cell therapy
  • Using our acquisitions as examples I will share insights into how we approach partnerships at AstraZeneca, including what we look for in a partner, what influences the structure of a deal and factors that have contributed to their success, including the importance of building mutually beneficial partnerships

9:30 am Panel Discussion: Effective Deal Structuring – What Do Pharma Want & What Can Biotech Offer

  • Gadi Bornstein Senior Director, External Innovation, Discovery, Product Development & Supply, Johnson & Johnson
  • Polly Brown Vice President & Head of Business Development, Oncology, Research & Development, AstraZeneca

Synopsis

  • Understanding what pharma is looking for to increase your chances of securing a partnership
  • Reimagining what an effective deal structure looks like to ensure it is advantageous to both parties
  • Finding the ideal deal structure for both pharma and biotech

10:30 am Morning Networking Break

Exploring Creative Partnerships & How They Can Help Maximize Your Chances for Partnerships with Pharma

11:00 am Roundtable Discussion: Brainstorm the Best Creative Partnership Ideas & Structure

Synopsis

  • Utilize learnings from the previous session to lay out a plan for a creative partnership
  • Map out the details of the partnership and gain feedback from industry peers

12:00 pm Networking Lunch

Pharma Matchmaking Roundtables

1:00 pm Utilize this Opportunity to Get Quality Face-to-Face Time with Leading Companies in the Cell Therapy Field

  • Deanna Mele Senior Director, Business Development Search & Evaluation, AstraZeneca
  • Christopher Tan Executive Director, Search & Evaluation, Business Development & Licensing, Merck
  • Hong Xin Senior Director Search & Evaluation, Johnson & Johnson

Synopsis

  • Rotate through the tables to understand how you align with their needs, search and evaluation interests, get feedback on your proposal strategies and more

4:00 pm End of Biotech & Pharma Partnering Day